Isavuconazole 200 mg IV tid for 6 doses followed by 200 mg IV daily
References
^Annie Lee, Brendan Prideaux, Min Hee Lee, Matthew Zimmerman, Enriko Dolgov, David S. Perlin, Yanan Zhao. Tissue Distribution and Penetration of Isavuconazole at the Site of Infection in Experimental Invasive Aspergillosis in Mice with Underlying Chronic Granulomatous Disease. Antimicrobial Agents and Chemotherapy. 2019;63(6). doi:10.1128/aac.00524-19.
^Felix Bergmann, Michael Wölfl-Duchek, Anselm Jorda, Valentin Al Jalali, Amelie Leutzendorff, Maria Sanz-Codina, Daniela Gompelmann, Karin Trimmel, Maria Weber, Sabine Eberl, Wisse Van Os, Iris K Minichmayr, Birgit Reiter, Thomas Stimpfl, Marco Idzko, Markus Zeitlinger. Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusions. Journal of Antimicrobial Chemotherapy. 2024;79(5):1169-1175. doi:10.1093/jac/dkae088.
^Matthew R Davis, Sandy Chang, Pryce Gaynor, Erin K McCreary, Paul Allyn. Isavuconazole for treatment of refractory coccidioidal meningitis with concomitant cerebrospinal fluid and plasma therapeutic drug monitoring. Medical Mycology. 2021;59(9):939-942. doi:10.1093/mmy/myab035.
^Claire Rouzaud, Vincent Jullien, Anne Herbrecht, Bruno Palmier, Simona Lapusan, Marjolaine Morgand, Romain Guéry, Amélie Dureault, François Danion, Stéphanie Puget, Lauriane Goldwirt, Fanny Lanternier, Olivier Lortholary. Isavuconazole Diffusion in Infected Human Brain. Antimicrobial Agents and Chemotherapy. 2019;63(10). doi:10.1128/aac.02474-18.
